Dr Tim Chambers explains the damaging effects of marketing of unhealthy commodities on children’s health and what we can do to tackle the problem.
Unhealthy commodities such as junk food, alcohol, and gambling are leading causes of non-communicable diseases, mental illness, injury, and many social harms. The collective global health burden of diet– and alcohol-related diseases is estimated at five million deaths each year. But what is the role of marketing of these unhealthy commodities in driving their growing consumption?
Unhealthy commodities marketing through the eyes of a child
Children’s exposure to unhealthy commodities marketing, regardless of the product, has an adverse impact on their health. For example, junk food marketing shapes children’s dietary preferences and alcohol marketing is positively associated with earlier onset drinking and the likelihood of engaging in hazardous drinking. Children are particularly susceptible to marketing as they are unable to fully comprehend the biases inherent in ads. But with the unprecedented access and engagement with different media, how much marketing for unhealthy commodities are children actually seeing on a daily basis? (more…)
To mark National Obesity Awareness Week, Professor Tricia Tan explains how new research is harnessing the power of hormones to treat obesity more effectively.
Obesity has been an issue for centuries. However, it has transformed from a disease that once only touched a small number of people to a major health concern that currently affects one in four adults in the UK. As a result, obesity is now always in the news. Although many obese people are reasonably healthy, we know that obesity increases the risks of developing heart disease, diabetes mellitus (high blood sugar), cancer, respiratory problems (such as sleep apnoea and asthma) and arthritis. Obesity and its related health problems threaten to reverse the gains in lifespan that we have seen through the 20th century. So, how can we begin to tackle it? (more…)
In this post, Dr Aruchuna Mohanaruban tackles the most asked questions about the EndoBarrier – a medical device for the treatment of type 2 diabetes and obesity.
UK obesity rates have continued to rise at an alarming rate, with figures higher than any other developed nation. Strongly associated with obesity is the increased susceptibility to developing type 2 diabetes (T2DM) which currently affects 3.2 million of the UK population. Bariatric surgery – a type of surgery aimed at inducing weight loss – usually by altering the stomach and/or intestines has revolutionised the treatment of these conditions and can lead to a 60% remission in diabetes. However, with demand for this type of surgery outstripping supply, there is a greater need to develop non-surgical alternatives to combat the ever-rising obesity and diabetes epidemic. (more…)